US Stock MarketDetailed Quotes

BCTX BriaCell Therapeutics

Watchlist
  • 3.470
  • -0.180-4.93%
Close Apr 1 16:00 ET
  • 3.410
  • -0.060-1.73%
Post 19:44 ET
12.87MMarket Cap-0.73P/E (TTM)

BriaCell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jan 31, 2025
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-19.71%5.01M
-57.55%5.79M
-95.94%862.09K
-95.94%862.09K
-96.68%935.69K
-81.36%6.24M
-63.56%13.65M
-48.22%21.25M
-48.22%21.25M
-36.74%28.17M
-Cash and cash equivalents
-19.71%5.01M
-57.55%5.79M
-95.94%862.09K
-95.94%862.09K
-96.68%935.69K
-81.36%6.24M
-63.56%13.65M
-48.22%21.25M
-48.22%21.25M
-36.74%28.17M
Receivables
7,028.61%2.15M
11,235.03%2.43M
90.74%1.37M
90.74%1.37M
2.26%15.23K
237.65%30.15K
-27.91%21.41K
2,877.81%717.74K
2,877.81%717.74K
2.50%14.9K
-Accounts receivable
7,028.61%2.15M
11,235.03%2.43M
----
----
2.26%15.23K
237.65%30.15K
-27.91%21.41K
----
----
2.50%14.9K
-Other receivables
----
----
90.74%1.37M
90.74%1.37M
----
----
----
--717.74K
--717.74K
----
Prepaid assets
----
----
-71.43%1.42M
-71.43%1.42M
247.43%4.58M
1,173.25%5.47M
538.81%4.74M
288.75%4.98M
288.75%4.98M
-21.78%1.32M
Total current assets
-39.00%7.16M
-55.35%8.22M
-86.44%3.65M
-86.44%3.65M
-81.26%5.53M
-65.40%11.74M
-51.84%18.41M
-36.36%26.95M
-36.36%26.95M
-36.18%29.5M
Non current assets
Net PPE
--342.5K
--365.34K
--388.18K
--388.18K
----
----
----
--0
--0
----
-Gross PPE
----
----
--456.8K
--456.8K
----
----
----
--0
--0
----
-Accumulated depreciation
----
----
---68.63K
---68.63K
----
----
----
--0
--0
----
Goodwill and other intangible assets
-7.36%192.16K
-7.23%195.98K
-7.10%199.8K
-7.10%199.8K
-6.98%203.61K
-6.86%207.43K
-6.74%211.25K
-6.63%215.07K
-6.63%215.07K
-6.52%218.89K
-Other intangible assets
----
----
-7.10%199.8K
-7.10%199.8K
----
----
----
-6.63%215.07K
-6.63%215.07K
----
Investments and advances
61.33%454.39K
21,098,650.00%421.98K
20,924,400.00%418.49K
20,924,400.00%418.49K
23,482,900.00%469.66K
14,082,750.00%281.66K
0.00%2
0.00%2
0.00%2
0.00%2
Non current prepaid assets
--1.21M
--1.21M
--1.21M
--1.21M
----
----
----
--0
--0
----
Total non current assets
350.02%2.2M
939.15%2.2M
931.48%2.22M
931.48%2.22M
207.59%673.27K
119.61%489.09K
-6.74%211.25K
-6.63%215.07K
-6.63%215.07K
-6.52%218.89K
Total assets
-23.44%9.36M
-44.07%10.41M
-78.38%5.87M
-78.38%5.87M
-79.13%6.2M
-64.20%12.23M
-51.58%18.62M
-36.20%27.16M
-36.20%27.16M
-36.03%29.72M
Liabilities
Current liabilities
Payables
34.81%5M
875.76%4.23M
538.12%7.17M
538.12%7.17M
545.30%6.42M
537.21%3.71M
-45.20%433.92K
142.56%1.12M
142.56%1.12M
--995.25K
-accounts payable
34.81%5M
875.76%4.23M
538.12%7.17M
538.12%7.17M
545.30%6.42M
537.21%3.71M
-45.20%433.92K
142.56%1.12M
142.56%1.12M
--995.25K
Current accrued expenses
6.92%227.6K
23.19%754.67K
-57.15%290.38K
-57.15%290.38K
-13.53%335.36K
142.00%212.87K
236.03%612.59K
41.84%677.72K
41.84%677.72K
--387.84K
Current liabilities
33.29%5.23M
376.69%4.99M
314.17%7.46M
314.17%7.46M
388.60%6.76M
485.36%3.92M
7.44%1.05M
91.42%1.8M
91.42%1.8M
277.59%1.38M
Non current liabilities
Derivative product liabilities
-94.55%905.84K
-88.62%1.71M
-96.24%1.1M
-96.24%1.1M
-83.41%5.68M
-52.19%16.62M
-44.53%15.06M
-6.92%29.14M
-6.92%29.14M
12,195.84%34.23M
Total non current liabilities
-94.55%905.84K
-88.62%1.71M
-96.24%1.1M
-96.24%1.1M
-83.41%5.68M
-52.19%16.62M
-44.53%15.06M
-6.92%29.14M
-6.92%29.14M
12,195.84%34.23M
Total liabilities
-70.14%6.14M
-58.38%6.7M
-72.34%8.56M
-72.34%8.56M
-65.08%12.44M
-42.02%20.55M
-42.73%16.1M
-4.05%30.94M
-4.05%30.94M
5,424.26%35.61M
Shareholders'equity
Share capital
22.79%85.45M
17.89%82.04M
3.70%72.17M
3.70%72.17M
6.10%69.59M
6.10%69.59M
6.10%69.59M
6.10%69.59M
6.10%69.59M
17.44%65.59M
-common stock
22.79%85.45M
17.89%82.04M
3.70%72.17M
3.70%72.17M
6.10%69.59M
6.10%69.59M
6.10%69.59M
6.10%69.59M
6.10%69.59M
17.44%65.59M
Retained earnings
-13.49%-97.54M
-22.23%-91.25M
-5.94%-85.44M
-5.94%-85.44M
-7.66%-84.23M
-17.19%-85.95M
-21.47%-74.65M
-33.64%-80.65M
-33.64%-80.65M
-183.63%-78.23M
Paid-in capital
----
----
----
----
----
----
24.90%7.92M
----
----
--6.89M
Gains losses not affecting retained earnings
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
Other equity interest
88.00%15.83M
--13.39M
48.66%11.03M
48.66%11.03M
--8.81M
--8.42M
----
--7.42M
--7.42M
----
Total stockholders'equity
144.63%3.6M
48.55%4.04M
36.93%-2.38M
36.93%-2.38M
-1.23%-5.97M
-530.42%-8.07M
-73.67%2.72M
-136.57%-3.78M
-136.57%-3.78M
-112.86%-5.89M
Noncontrolling interests
-53.85%-376.03K
-60.70%-329.62K
---302.52K
---302.52K
---267.94K
---244.42K
---205.11K
--0
--0
----
Total equity
138.80%3.23M
47.56%3.71M
28.92%-2.68M
28.92%-2.68M
-5.78%-6.23M
-549.50%-8.32M
-75.65%2.52M
-136.57%-3.78M
-136.57%-3.78M
-112.86%-5.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jan 31, 2025(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -19.71%5.01M-57.55%5.79M-95.94%862.09K-95.94%862.09K-96.68%935.69K-81.36%6.24M-63.56%13.65M-48.22%21.25M-48.22%21.25M-36.74%28.17M
-Cash and cash equivalents -19.71%5.01M-57.55%5.79M-95.94%862.09K-95.94%862.09K-96.68%935.69K-81.36%6.24M-63.56%13.65M-48.22%21.25M-48.22%21.25M-36.74%28.17M
Receivables 7,028.61%2.15M11,235.03%2.43M90.74%1.37M90.74%1.37M2.26%15.23K237.65%30.15K-27.91%21.41K2,877.81%717.74K2,877.81%717.74K2.50%14.9K
-Accounts receivable 7,028.61%2.15M11,235.03%2.43M--------2.26%15.23K237.65%30.15K-27.91%21.41K--------2.50%14.9K
-Other receivables --------90.74%1.37M90.74%1.37M--------------717.74K--717.74K----
Prepaid assets ---------71.43%1.42M-71.43%1.42M247.43%4.58M1,173.25%5.47M538.81%4.74M288.75%4.98M288.75%4.98M-21.78%1.32M
Total current assets -39.00%7.16M-55.35%8.22M-86.44%3.65M-86.44%3.65M-81.26%5.53M-65.40%11.74M-51.84%18.41M-36.36%26.95M-36.36%26.95M-36.18%29.5M
Non current assets
Net PPE --342.5K--365.34K--388.18K--388.18K--------------0--0----
-Gross PPE ----------456.8K--456.8K--------------0--0----
-Accumulated depreciation -----------68.63K---68.63K--------------0--0----
Goodwill and other intangible assets -7.36%192.16K-7.23%195.98K-7.10%199.8K-7.10%199.8K-6.98%203.61K-6.86%207.43K-6.74%211.25K-6.63%215.07K-6.63%215.07K-6.52%218.89K
-Other intangible assets ---------7.10%199.8K-7.10%199.8K-------------6.63%215.07K-6.63%215.07K----
Investments and advances 61.33%454.39K21,098,650.00%421.98K20,924,400.00%418.49K20,924,400.00%418.49K23,482,900.00%469.66K14,082,750.00%281.66K0.00%20.00%20.00%20.00%2
Non current prepaid assets --1.21M--1.21M--1.21M--1.21M--------------0--0----
Total non current assets 350.02%2.2M939.15%2.2M931.48%2.22M931.48%2.22M207.59%673.27K119.61%489.09K-6.74%211.25K-6.63%215.07K-6.63%215.07K-6.52%218.89K
Total assets -23.44%9.36M-44.07%10.41M-78.38%5.87M-78.38%5.87M-79.13%6.2M-64.20%12.23M-51.58%18.62M-36.20%27.16M-36.20%27.16M-36.03%29.72M
Liabilities
Current liabilities
Payables 34.81%5M875.76%4.23M538.12%7.17M538.12%7.17M545.30%6.42M537.21%3.71M-45.20%433.92K142.56%1.12M142.56%1.12M--995.25K
-accounts payable 34.81%5M875.76%4.23M538.12%7.17M538.12%7.17M545.30%6.42M537.21%3.71M-45.20%433.92K142.56%1.12M142.56%1.12M--995.25K
Current accrued expenses 6.92%227.6K23.19%754.67K-57.15%290.38K-57.15%290.38K-13.53%335.36K142.00%212.87K236.03%612.59K41.84%677.72K41.84%677.72K--387.84K
Current liabilities 33.29%5.23M376.69%4.99M314.17%7.46M314.17%7.46M388.60%6.76M485.36%3.92M7.44%1.05M91.42%1.8M91.42%1.8M277.59%1.38M
Non current liabilities
Derivative product liabilities -94.55%905.84K-88.62%1.71M-96.24%1.1M-96.24%1.1M-83.41%5.68M-52.19%16.62M-44.53%15.06M-6.92%29.14M-6.92%29.14M12,195.84%34.23M
Total non current liabilities -94.55%905.84K-88.62%1.71M-96.24%1.1M-96.24%1.1M-83.41%5.68M-52.19%16.62M-44.53%15.06M-6.92%29.14M-6.92%29.14M12,195.84%34.23M
Total liabilities -70.14%6.14M-58.38%6.7M-72.34%8.56M-72.34%8.56M-65.08%12.44M-42.02%20.55M-42.73%16.1M-4.05%30.94M-4.05%30.94M5,424.26%35.61M
Shareholders'equity
Share capital 22.79%85.45M17.89%82.04M3.70%72.17M3.70%72.17M6.10%69.59M6.10%69.59M6.10%69.59M6.10%69.59M6.10%69.59M17.44%65.59M
-common stock 22.79%85.45M17.89%82.04M3.70%72.17M3.70%72.17M6.10%69.59M6.10%69.59M6.10%69.59M6.10%69.59M6.10%69.59M17.44%65.59M
Retained earnings -13.49%-97.54M-22.23%-91.25M-5.94%-85.44M-5.94%-85.44M-7.66%-84.23M-17.19%-85.95M-21.47%-74.65M-33.64%-80.65M-33.64%-80.65M-183.63%-78.23M
Paid-in capital ------------------------24.90%7.92M----------6.89M
Gains losses not affecting retained earnings 0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K
Other equity interest 88.00%15.83M--13.39M48.66%11.03M48.66%11.03M--8.81M--8.42M------7.42M--7.42M----
Total stockholders'equity 144.63%3.6M48.55%4.04M36.93%-2.38M36.93%-2.38M-1.23%-5.97M-530.42%-8.07M-73.67%2.72M-136.57%-3.78M-136.57%-3.78M-112.86%-5.89M
Noncontrolling interests -53.85%-376.03K-60.70%-329.62K---302.52K---302.52K---267.94K---244.42K---205.11K--0--0----
Total equity 138.80%3.23M47.56%3.71M28.92%-2.68M28.92%-2.68M-5.78%-6.23M-549.50%-8.32M-75.65%2.52M-136.57%-3.78M-136.57%-3.78M-112.86%-5.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +29.96%
Sample Name
Sample Code
 +24.59%
Sample Name
Sample Code
 +20.05%
4
Tibet Duo Rui Pharmaceutical
301075
+20.02%
5
Chengda Pharmaceuticals
301201
+20.01%
Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 306.020
Sample Name
Sample Code
 268.460
Sample Name
Sample Code
 11.840
4
Microsoft
MSFT
382.190
5
Alphabet-C
GOOG
158.880
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 268.460
Sample Name
Sample Code
 382.190
Sample Name
Sample Code
 158.880
4
Meta Platforms
META
586.000
5
NVIDIA
NVDA
110.150
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 13.320
Sample Name
Sample Code
 7.560
Sample Name
Sample Code
 6.640
4
Cipher Mining
CIFR
2.460
5
Hive Blockchain
HIVE
1.540
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -